Topical alpha-selective p38 MAP kinase inhibition reduces acute skin inflammation in guinea pig
Open Access
- 1 February 2010
- journal article
- Published by Taylor & Francis in Journal of Inflammation Research
- Vol. 3, 9-16
Abstract
Peer reviewed article authored by (Satyanarayana Medicherla, Jing Ying Ma, Mamtha Reddy, et al). Read article or submit your manuscript for publishing.Keywords
This publication has 30 references indexed in Scilit:
- TOPICAL p38MAPK INHIBITION REDUCES DERMAL INFLAMMATION AND EPITHELIAL APOPTOSIS IN BURN WOUNDSShock, 2006
- Preventive and Therapeutic Potential of p38α-Selective Mitogen-Activated Protein Kinase Inhibitor in Nonobese Diabetic Mice with Type 1 DiabetesThe Journal of Pharmacology and Experimental Therapeutics, 2006
- A clinician's paradigm in the treatment of psoriasisJournal of the American Academy of Dermatology, 2005
- Role of p38 MAPK in UVB-Induced Inflammatory Responses in the Skin of SKH-1 Hairless MiceJournal of Investigative Dermatology, 2005
- In vitro/in vivo correlation studies for transdermal Δ8-THC developmentJournal of Pharmaceutical Sciences, 2004
- p38 Mitogen-Activated Protein Kinase Inhibitor Protects the Epidermis Against the Acute Damaging Effects of Ultraviolet Irradiation by Blocking Apoptosis and Inflammatory ResponsesJournal of Investigative Dermatology, 2004
- Lipopolysaccharide Activates Matrix Metalloproteinase-2 in Endothelial Cells through an NF-κB-Dependent PathwayBiochemical and Biophysical Research Communications, 2000
- Role of neutrophils in induction of acute inflammation in T‐cell‐mediated immune dermatosis, psoriasis: A neutrophil‐associated inflammation‐boosting loopExperimental Dermatology, 2000
- Histamine and cutaneous nociception: histamine-induced responses in patients with atopic eczema, psoriasis and urticariaActa Dermato-Venereologica, 1998
- Novel Homologues of CSBP/p38 MAP Kinase: Activation, Substrate Specificity and Sensitivity to Inhibition by Pyridinyl ImidazolesBiochemical and Biophysical Research Communications, 1997